RARS1 and breast carcinoma: Previous studies demonstrated that the growth of human breast tumor cells is regulated by signalling pathways involving nuclear steroid thyroxine receptors [40], especially RARs, which show growth inhibitory activity against breast cancer cells both in vitro and in vivo [41].Interestingly, RAR and ER share a common coactivator, estradiol.